Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Yu Y. Molecular classification and precision therapy of cancer: immune checkpoint inhibitors. Front Med 2018; 12(2): 229–255
2. Xiang Z, Zhou Z, Song S, Li J, Ji J, Yan R, Wang J, Cai W, Hu W, Zang L, Zhu Z, Zhang Z, Li M, Yu Y. Dexamethasone suppresses immune evasion by inducing GR/STAT5 mediated downregulation of PD-L1 and IDO1 pathways. Oncogene 2021; 80(51): 5002–5012
3. O’Connell E, Salvucci M, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Mucinous colorectal cancer is associated with expression of the TIM-5 immune checkpoint independently of microsatellite instability (MSI) status. Ann Surg Oncol 2021; 28(12): 7999–8006
4. Wang J, Sanmamed MF, Datar I, Su TT, Ji L, Sun J, Chen L, Chen Y, Zhu G, Yin W, Zheng L, Zhou T, Badri T, Yao S, Zhu S, Boto A, Sznol M, Melero I, Vignali DAA, Schalper K, Chen L. Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-5. Cell 2019; 176(1–2): 558–587.e12
5. Jin HS, Park Y. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy. BMB Rep 2021; 58(1): 2–11
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献